Digital Inhaler Use in Obstructive Lung Disease Care

This is a pilot study to evaluate the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control. The primary objective is to evaluate feasibility of study protocol, patient recruitment, and patient retention with goal recruitment of 20 participants, 60% recruitment success, and 60% retention rate for 6 months duration. The secondary objectives are the evaluation of patient admission rate, exacerbation rates, and symptoms control with use of digital inhaler technology The subject population will be patients with physician diagnosed obstructive lung disease.

NCT Number	NCT07214337
Lead Sponsor	Cedars-Sinai Medical Center Collaborators: Breathe California, Los Angeles County
Conditions	Chronic Obstructive Airways Disease Exacerbated, Chronic Obstructive Airway Disease
Enrollment	20 participants
Start Date	2025-11-01
Primary Completion	2027-01 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2025-10-09